CA2325225A1 - Identification de systemes non lineaires pour la prevision des classes en bioinformatique et dans des applications connexes - Google Patents

Identification de systemes non lineaires pour la prevision des classes en bioinformatique et dans des applications connexes Download PDF

Info

Publication number: CA2325225A1
Authority: CA; Canada
Prior art keywords: training; output; input; cascade; sequences
Prior art date: 2000-11-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2325225

Other languages

English (en)

Inventor

Michael J. Korenberg

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-03

Filing date

2000-11-20

Publication date

2002-05-03

2000-11-20 Application filed by Individual filed Critical Individual

2001-11-05 Priority to PCT/CA2001/001552 priority Critical patent/WO2002037202A2/fr

2001-11-05 Priority to AU2002214871A priority patent/AU2002214871A1/en

2001-11-05 Priority to CA002465661A priority patent/CA2465661A1/fr

2001-11-05 Priority to AU14874/02A priority patent/AU1487402A/en

2001-11-05 Priority to PCT/CA2001/001547 priority patent/WO2002036812A2/fr

2001-11-05 Priority to EP01983359A priority patent/EP1466289A2/fr

2002-05-03 Publication of CA2325225A1 publication Critical patent/CA2325225A1/fr

2003-05-05 Priority to US10/428,776 priority patent/US20030195706A1/en

2007-05-04 Priority to US11/744,599 priority patent/US20070276610A1/en

Status Abandoned legal-status Critical Current

Links

238000012549 training Methods 0.000 claims abstract description 216
108090000623 proteins and genes Proteins 0.000 claims abstract description 169
238000000034 method Methods 0.000 claims abstract description 120
230000003068 static effect Effects 0.000 claims description 54
230000014509 gene expression Effects 0.000 claims description 49
102000004169 proteins and genes Human genes 0.000 abstract description 129
238000012360 testing method Methods 0.000 abstract description 83
238000013456 study Methods 0.000 abstract description 40
108091092195 Intron Proteins 0.000 abstract description 36
108700024394 Exon Proteins 0.000 abstract description 25
108091028043 Nucleic acid sequence Proteins 0.000 abstract description 21
108020004414 DNA Proteins 0.000 abstract description 11
238000004458 analytical method Methods 0.000 abstract description 10
108091026890 Coding region Proteins 0.000 abstract description 7
238000001514 detection method Methods 0.000 abstract description 5
108091008874 T cell receptors Proteins 0.000 abstract description 3
102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract description 3
230000001537 neural effect Effects 0.000 abstract description 2
102000005701 Calcium-Binding Proteins Human genes 0.000 description 83
108010045403 Calcium-Binding Proteins Proteins 0.000 description 83
150000001413 amino acids Chemical class 0.000 description 74
108091000080 Phosphotransferase Proteins 0.000 description 71
102000018146 globin Human genes 0.000 description 71
108060003196 globin Proteins 0.000 description 71
102000020233 phosphotransferase Human genes 0.000 description 71
230000000875 corresponding effect Effects 0.000 description 57
238000013459 approach Methods 0.000 description 51
230000006870 function Effects 0.000 description 34
208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 32
208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 31
208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 31
208000031261 Acute myeloid leukaemia Diseases 0.000 description 28
208000033776 Myeloid Acute Leukemia Diseases 0.000 description 26
238000011156 evaluation Methods 0.000 description 17
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 17
239000002773 nucleotide Substances 0.000 description 14
125000003729 nucleotide group Chemical group 0.000 description 14
241000586555 Aulacaspis rosae Species 0.000 description 12
238000012935 Averaging Methods 0.000 description 10
238000004422 calculation algorithm Methods 0.000 description 10
230000001965 increasing effect Effects 0.000 description 10
241000282320 Panthera leo Species 0.000 description 9
230000004071 biological effect Effects 0.000 description 9
239000000523 sample Substances 0.000 description 9
102000001253 Protein Kinase Human genes 0.000 description 8
108060006633 protein kinase Proteins 0.000 description 8
230000008901 benefit Effects 0.000 description 7
230000009467 reduction Effects 0.000 description 7
238000011160 research Methods 0.000 description 7
238000012795 verification Methods 0.000 description 7
206010028980 Neoplasm Diseases 0.000 description 6
241000220317 Rosa Species 0.000 description 6
230000008859 change Effects 0.000 description 6
238000012216 screening Methods 0.000 description 6
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 6
108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
125000003275 alpha amino acid group Chemical group 0.000 description 5
150000001875 compounds Chemical class 0.000 description 5
238000009826 distribution Methods 0.000 description 5
238000011835 investigation Methods 0.000 description 5
230000008569 process Effects 0.000 description 5
238000012545 processing Methods 0.000 description 5
239000002253 acid Substances 0.000 description 4
150000001768 cations Chemical class 0.000 description 4
230000000295 complement effect Effects 0.000 description 4
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
230000003111 delayed effect Effects 0.000 description 4
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
230000026731 phosphorylation Effects 0.000 description 4
238000006366 phosphorylation reaction Methods 0.000 description 4
-1 polarity Chemical class 0.000 description 4
238000005316 response function Methods 0.000 description 4
150000003384 small molecules Chemical class 0.000 description 4
229930024421 Adenine Natural products 0.000 description 3
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
229960000643 adenine Drugs 0.000 description 3
238000013528 artificial neural network Methods 0.000 description 3
230000002596 correlated effect Effects 0.000 description 3
238000007876 drug discovery Methods 0.000 description 3
238000010606 normalization Methods 0.000 description 3
238000007781 pre-processing Methods 0.000 description 3
230000012846 protein folding Effects 0.000 description 3
230000004044 response Effects 0.000 description 3
238000002864 sequence alignment Methods 0.000 description 3
239000000126 substance Substances 0.000 description 3
229940113082 thymine Drugs 0.000 description 3
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
108091006112 ATPases Proteins 0.000 description 2
102000057290 Adenosine Triphosphatases Human genes 0.000 description 2
241001123248 Arma Species 0.000 description 2
241000511343 Chondrostoma nasus Species 0.000 description 2
108700026244 Open Reading Frames Proteins 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
238000007635 classification algorithm Methods 0.000 description 2
239000002131 composite material Substances 0.000 description 2
238000005094 computer simulation Methods 0.000 description 2
238000010276 construction Methods 0.000 description 2
229940104302 cytosine Drugs 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
238000001914 filtration Methods 0.000 description 2
238000013467 fragmentation Methods 0.000 description 2
238000006062 fragmentation reaction Methods 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
230000006872 improvement Effects 0.000 description 2
238000013507 mapping Methods 0.000 description 2
238000002493 microarray Methods 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
230000000704 physical effect Effects 0.000 description 2
150000003212 purines Chemical class 0.000 description 2
150000003230 pyrimidines Chemical class 0.000 description 2
238000012731 temporal analysis Methods 0.000 description 2
238000000700 time series analysis Methods 0.000 description 2
230000007704 transition Effects 0.000 description 2
VXQBJTKSVGFQOL-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethyl acetate Chemical compound CCCCOCCOCCOC(C)=O VXQBJTKSVGFQOL-UHFFFAOYSA-N 0.000 description 1
240000000662 Anethum graveolens Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
240000005589 Calophyllum inophyllum Species 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
241000072967 Cyathea ars Species 0.000 description 1
101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 description 1
241000272168 Laridae Species 0.000 description 1
101100293261 Mus musculus Naa15 gene Proteins 0.000 description 1
101150082943 NAT1 gene Proteins 0.000 description 1
WXOMTJVVIMOXJL-BOBFKVMVSA-A O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O WXOMTJVVIMOXJL-BOBFKVMVSA-A 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
240000002834 Paulownia tomentosa Species 0.000 description 1
235000010678 Paulownia tomentosa Nutrition 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
241000220324 Pyrus Species 0.000 description 1
241000231739 Rutilus rutilus Species 0.000 description 1
CPGKMLVTFNUAHL-UHFFFAOYSA-N [Ca].[Ca] Chemical compound [Ca].[Ca] CPGKMLVTFNUAHL-UHFFFAOYSA-N 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
235000015107 ale Nutrition 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
230000001364 causal effect Effects 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
238000004891 communication Methods 0.000 description 1
238000005314 correlation function Methods 0.000 description 1
238000002790 cross-validation Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000010586 diagram Methods 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
230000004049 epigenetic modification Effects 0.000 description 1
230000000763 evoking effect Effects 0.000 description 1
238000005562 fading Methods 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
238000013100 final test Methods 0.000 description 1
239000012634 fragment Substances 0.000 description 1
102000055647 human CSF2RB Human genes 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000010365 information processing Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
238000011089 mechanical engineering Methods 0.000 description 1
230000003340 mental effect Effects 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000008450 motivation Effects 0.000 description 1
230000035772 mutation Effects 0.000 description 1
208000018360 neuromuscular disease Diseases 0.000 description 1
238000005312 nonlinear dynamic Methods 0.000 description 1
238000002966 oligonucleotide array Methods 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
238000003909 pattern recognition Methods 0.000 description 1
235000021017 pears Nutrition 0.000 description 1
102000054765 polymorphisms of proteins Human genes 0.000 description 1
238000004088 simulation Methods 0.000 description 1
ZFMRLFXUPVQYAU-UHFFFAOYSA-N sodium 5-[[4-[4-[(7-amino-1-hydroxy-3-sulfonaphthalen-2-yl)diazenyl]phenyl]phenyl]diazenyl]-2-hydroxybenzoic acid Chemical compound C1=CC(=CC=C1C2=CC=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)O)N=NC5=CC(=C(C=C5)O)C(=O)O.[Na+] ZFMRLFXUPVQYAU-UHFFFAOYSA-N 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
238000010183 spectrum analysis Methods 0.000 description 1
238000000528 statistical test Methods 0.000 description 1
238000012916 structural analysis Methods 0.000 description 1
239000013589 supplement Substances 0.000 description 1

Landscapes

Management, Administration, Business Operations System, And Electronic Commerce (AREA)

CA 2325225 2000-11-03 2000-11-20 Identification de systemes non lineaires pour la prevision des classes en bioinformatique et dans des applications connexes Abandoned CA2325225A1 (fr)

Priority Applications (8)

Application Number	Priority Date	Filing Date	Title
PCT/CA2001/001552 WO2002037202A2 (fr)	2000-11-03	2001-11-05	IDENTIFICATION D'UN SYSTEME NON LINEAIRE POUR LA PREVISION DE CLASSES EN BIOINFORMATIQUE ET DANS DES APPLICATIONS CONNEXES
AU2002214871A AU2002214871A1 (en)	2000-11-03	2001-11-05	Nonlinear system identification for class prediction in bioinformatics and related applications
CA002465661A CA2465661A1 (fr)	2000-11-03	2001-11-05	Identification d'un systeme non lineaire pour la prevision de classes en bioinformatique est dans des applications connexes
AU14874/02A AU1487402A (en)	2000-11-03	2001-11-05	Nonlinear system identification for class prediction in bioinformatics and related applications
PCT/CA2001/001547 WO2002036812A2 (fr)	2000-11-03	2001-11-05	Identification d'un systeme non lineaire pour la prevision de classes en bioinformatique est dans des applications connexes
EP01983359A EP1466289A2 (fr)	2000-11-03	2001-11-05	Identification d'un systeme non lineaire pour la prevision de classes en bioinformatique est dans des applications connexes
US10/428,776 US20030195706A1 (en)	2000-11-20	2003-05-05	Method for classifying genetic data
US11/744,599 US20070276610A1 (en)	2000-11-20	2007-05-04	Method for classifying genetic data

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US24523600P	2000-11-03	2000-11-03
US60/245,236		2000-11-03

Publications (1)

Publication Number	Publication Date
CA2325225A1 true CA2325225A1 (fr)	2002-05-03

Family

ID=22925855

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2325225 Abandoned CA2325225A1 (fr)	2000-11-03	2000-11-20	Identification de systemes non lineaires pour la prevision des classes en bioinformatique et dans des applications connexes

Country Status (1)

Country	Link
CA (1)	CA2325225A1 (fr)

2000
- 2000-11-20 CA CA 2325225 patent/CA2325225A1/fr not_active Abandoned

Publication	Publication Date	Title
US20030195706A1 (en)	2003-10-16	Method for classifying genetic data
Shahmuradov et al.	2005	Plant promoter prediction with confidence estimation
Leng et al.	2006	Classification using functional data analysis for temporal gene expression data
Pal et al.	2006	Evolutionary computation in bioinformatics: A review
Lukashin et al.	2001	Analysis of temporal gene expression profiles: clustering by simulated annealing and determining the optimal number of clusters
Han et al.	2003	A domain combination based probabilistic framework for protein-protein interaction prediction
Gharib et al.	2023	Harnessing tree soft set and soft computing techniques' capabilities in bioinformatics: analysis, improvements, and applications
Reddy et al.	2025	HybridPPI: A Hybrid Machine Learning Framework for Protein-Protein Interaction Prediction
WO2002037202A2 (fr)	2002-05-10	IDENTIFICATION D&apos;UN SYSTEME NON LINEAIRE POUR LA PREVISION DE CLASSES EN BIOINFORMATIQUE ET DANS DES APPLICATIONS CONNEXES
Nicorici et al.	2004	Segmentation of DNA into coding and noncoding regions based on recursive entropic segmentation and stop-codon statistics
Korenberg et al.	2000	Automatic classification of protein sequences into structure/function groups via parallel cascade identification: a feasibility study
To et al.	2007	A parallel genetic algorithm for single class pattern classification and its application for gene expression profiling in Streptomyces coelicolor
CA2325225A1 (fr)	2002-05-03	Identification de systemes non lineaires pour la prevision des classes en bioinformatique et dans des applications connexes
Jaiswal et al.	2019	Physicochemical property based computational scheme for classifying DNA sequence elements of Saccharomyces cerevisiae
Kivioja et al.	2002	Assigning probes into a small number of pools separable by electrophoresis
Wu et al.	2014	Predicting nucleosome positioning based on geometrically transformed tsallis entropy
Damasevicius	2008	Analysis of binary feature mapping rules for promoter recognition in imbalanced DNA sequence datasets using support vector machine
Shin et al.	2009	EvoOligo: oligonucleotide probe design with multiobjective evolutionary algorithms
Mazidi et al.	2020	PSPGA: A New Method for Protein Structure Prediction based on Genetic Algorithm
EP1709565B1 (fr)	2007-08-01	Logiciel permettant d'identifier des snp a l'aide de jeux ordonnes de microechantillons
Toledo Iglesias	2024	Exploring genetic patterns in cancer transcriptomes: an unsupervised learning approach
Perera et al.	2008	DNA binding site characterization by means of Renyi entropy measures on nucleotide transitions
Korenberg et al.	2002	Parallel cascade recognition of exon and intron DNA sequences
Lee et al.	2001	Evolution strategy applied to global optimization of clusters in gene expression data of DNA microarrays
DE LA VEGA	2019	Notes for the CABANA Workshop:“Genomic analysis of crop diversity using R”–June 25 to 28, 2019–Langebio Cinvestav Irapuato, México.

Legal Events

Date	Code	Title	Description
2005-11-16	EEER	Examination request
2013-01-15	FZDE	Dead	Effective date: 20121120